Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Clinical trial NCT02319837 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02319837
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hormone Sensitive Prostate Cancer Prostate Cancer Cancer of the Prostate

Start date: 2014-12-17
Primary completion: 2023-01-31
Enrollment: 1068

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.